Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II

A P Coletta; A A Louis; A L Clark; N Nikitin; J G F Cleland; European Society of Cardiology

doi:10.1016/s1388-9842(02)00176-9

Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II

Eur J Heart Fail. 2002 Oct;4(5):661-6. doi: 10.1016/s1388-9842(02)00176-9.

Authors

A P Coletta¹, A A Louis, A L Clark, N Nikitin, J G F Cleland; European Society of Cardiology

Affiliation

¹ Department of Academic Cardiology, University of Hull, Castle Hull Hospital, Kingston-upon-Hull HU15 5JQ, Cottingham, UK. [email protected]

PMID: 12413511
DOI: 10.1016/s1388-9842(02)00176-9

Abstract

This article continues a series of reports on research developments related to the field of heart failure. Reports of presentations made at the Hot Line sessions of the European Society of Cardiology XXIV Congress held in Berlin, Germany, between 31 August and 4 September 2002 are included. Summaries of the results of the following trials are presented: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II.

MeSH terms

Cardiology*
Clinical Trials as Topic / trends*
Europe
Heart Failure / therapy
Humans
Societies, Medical*
Ventricular Dysfunction, Left / therapy